Evidence map›Paper›PMID 37636014›Full record

ArticleAnnals of the Child Neurology Society2023

Effect of neonatal seizure burden and etiology on the long-term outcome: data from a randomized, controlled trial.

Sara K Trowbridge, Lois O Condie, Jessica R Landers, Ann M Bergin, Patricia E Grant, Kalpathy Krishnamoorthy, Valerie Rofeberg, David Wypij, Kevin J Staley, Janet S Soul and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of the Child Neurology Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Review
  5. Review
  6. Article
  7. Developmental milestones as ACNS turns one year old.Annals of the Child Neurology Society · 2023
    Article
  8. Investigating the Impact on Long-Term Outcomes and the Necessity of Hereditary Thrombophilia Screening in Presumed or Perinatal Arterial Ischemic Stroke.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sara K TrowbridgeDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Lois O CondieDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Jessica R LandersDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Ann M BerginDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Patricia E GrantDepartment of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Kalpathy KrishnamoorthyDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Valerie RofebergDepartment of Cardiology, Boston Children's Hospital, Boston, MA.
David WypijDepartment of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Kevin J StaleyDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Janet S SoulDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Boston Bumetanide Trial Group
Boston Children's Hospital · USHarvard University · US

Funding

Neuronal Ion and Volume Shifts After Acute Brain InjuryR35NS116852 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Kevin J. Staley · 2020 to 2026
$8.0M
Pilot Trial of Bumetanide for Neonatal SeizuresR01NS066929 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI SOUL, JANET SUSAN · 2010 to 2014
$3.0M
NINDS NIH HHS R01 NS066929NINDS NIH HHS R35 NS116852
6 · The paper itself

Abstract

Background: Neonatal seizures are common, but the impact of neonatal seizures on long-term neurologic outcome remains unclear. We addressed this question by analyzing data from an early-phase controlled trial of bumetanide to treat neonatal seizures. Methods: Neonatal seizure burden was calculated from continuous video-EEG data. Neurologic outcome was determined by standardized developmental tests and post-neonatal seizure recurrence. Results: Of 111 enrolled neonates, 43 were randomized to treatment or control groups. There were no differences in neurologic outcome between treatment and control groups. A subgroup analysis was performed for 84 neonates with acute perinatal brain injury (57 HIE, 18 stroke, 9 ICH), most of whom (70%) had neonatal seizures. There was a significant negative correlation between seizure burden and developmental scores (p<0.01). Associations between seizure burden and developmental scores were stronger in HIE and stroke groups compared with ICH (p<0.05). Conclusion: Bumetanide showed no long-term beneficial or adverse effects, as expected based on treatment duration versus duration of neonatal seizures. For neonates with perinatal brain injury, higher neonatal seizure burden correlated significantly with worse developmental outcome, particularly for ischemic versus hemorrhagic brain injury. These data highlight the need for further investigation of the long-term effects of both neonatal seizure severity and etiology.

Indexed as

BumetanideHypoxic ischemic encephalopathyIntracranial hemorrhageNeonatal seizuresStroke

Identifiers

PMID37636014
PMCPMC10449023
OpenAlexW4318214587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.